Stem Cell Manufacturing Market Worth USD 21 Billion by 2030 at 11.2% CAGR - Report by Market Research Future (MRFR)
30 juin 2022 06h27 HE
|
Market Research Future
New York, USA, June 30, 2022 (GLOBE NEWSWIRE) -- Stem Cell Manufacturing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Stem Cell...
ExCellThera announces submission of Drug Master File for UM171
17 juin 2022 08h05 HE
|
ExCellThera
MONTRÉAL, June 17, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and...
STEMTECH CORPORATION CHAIRMAN AND CEO CHARLES ARNOLD RECEIVES GLOBAL EAGLES BUSINESS LEADER OF THE YEAR AWARD
16 juin 2022 09h00 HE
|
Stemtech Corporation
MIRAMAR, FL, June 16, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today...
Natural Skincare Brand, Frownies, Releases New Skin-Renewing Apple Serum With the Power of Plant-Based Stem Cell Technology
14 avr. 2022 09h00 HE
|
Frownies
DAYTON, Ohio, April 14, 2022 (GLOBE NEWSWIRE) -- Frownies, the wrinkle-smoothing expert since 1889, has expanded its skincare line beyond its wildly popular Frownies Facial Patches to include...
Throne Biotechnologies Wins '5 Best BioTech Companies To Watch' Award From The Silicon Review
28 mars 2022 09h00 HE
|
Throne Biotechnologies Inc
PARAMUS, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Throne Biotechnologies (Throne), one of the global-leading biotech companies aiming to find a cure for type 1 diabetes and other autoimmune...
ExCellThera announces first patient treated in Phase I/II trial of ECT-001 cell therapy for pediatric patients with high risk blood cancer
10 mars 2022 08h04 HE
|
ExCellThera
MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and...
BioRestorative Therapies Awarded One of Top 10 Spine Device Companies by MedTech Outlook
19 août 2021 06h00 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 19, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies,...
Global Cancer Stem Cells Market to Surpass $1,898.3 Million, Growing with a CAGR of 11.8% from 2019 to 2026, Post-COVID-19 Disaster by Research Dive
17 août 2021 09h02 HE
|
Research Dive
New York, USA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A newest report on the global cancer stem cells market has been added by Research Dive to its repository. The report presents exhaustive insights on...
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
09 août 2021 11h58 HE
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
ExCellThera and Astellas enter into a license for the use of molecule UM171 in the field of pluripotent stem cells
13 juil. 2021 08h05 HE
|
ExCellThera
MONTREAL, July 13, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), a clinical-stage molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune...